Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
The Hastings Center Report|April 19, 2019
Federal Right to Try: Where Is It Going?Kelly Folkers, Carolyn Chapman, Barbara RedmanProstate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.Oncotarget|December 22, 2017
Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomyAshley E Ross, Robert M Hughes, Stephanie Glavaris, et al.Nature Medicine|April 3, 2023
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trialEugene Shenderov, Angelo M De Marzo, Tamara L Lotan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.Pageof 1